Genome‐Wide Association Analysis Identifies LILRB2 Gene for Pathological Myopia

Lingxi Jiang,Lulin Huang,Chao Dai,Rui Zheng,Masahiro Miyake,Yuki Mori,Shin‐ya Nakao,Kazuya Morino,Kenji Ymashiro,Yang‐Bao Miao,Qi Li,Weiming Ren,Zimeng Ye,Hongjing Li,Zhenglin Yang,Yi Shi
DOI: https://doi.org/10.1002/advs.202308968
IF: 15.1
2024-09-02
Advanced Science
Abstract:Pathological myopia (PM) is a leading cause of blindness. To uncover the genetic basis of PM, an extensive two‐stage genome‐wide association study and replication analysis in East Asian populations is conducted. These findings reveal that elevated expression of LILRB2/Pirb disrupts lipid metabolism, impairing choroidal function, and promoting PM progression. These insights pave the way for innovative therapeutic strategies targeting PM. Pathological myopia (PM) is one of the leading causes of blindness, especially in Asia. To identify the genetic risk factors of PM, a two‐stage genome‐wide association study (GWAS) and replication analysis in East Asian populations is conducted. The analysis identified LILRB2 in 19q13.42 as a new candidate locus for PM. The increased protein expression of LILRB2/Pirb (mouse orthologous protein) in PM patients and myopia mouse models is validated. It is further revealed that the increase in LILRB2/Pirb promoted fatty acid synthesis and lipid accumulation, leading to the destruction of choroidal function and the development of PM. This study revealed the association between LILRB2 and PM, uncovering the molecular mechanism of lipid metabolism disorders leading to the pathogenesis of PM due to LILRB2 upregulation.
materials science, multidisciplinary,nanoscience & nanotechnology,chemistry
What problem does this paper attempt to address?